Cambridge U. Begins New Collaboration with GSK
The InPharm website announced that the University of Cambridge has begun a new collaboration with GlaxoSmithKline. The collaboration will see researchers from both sides working together at the Stevenage Bioscience Catalyst, the UK’s first open innovation bioscience campus. “A key element of the open innovation environment fostered through the bioscience park is enabling scientific exchange to flourish without the need for exclusive research collaboration agreements between partners,” the University said.
Click here to read the full article.